Biocon posts Rs 306 cr net profit in Q2FY16
Revenues were reported at Rs 861 crores
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Kiran Mazumdar-Shaw
Syngene International IPO oversubscribed 31 times
The IPO is an offer for sale (OFS) by Biocon of a part of its shareholding in Syngene
Syngene International's (Syngene) Initial…
Kiran Mazumdar-Shaw in Scientific American’s 100 Biotech visionaries list
Only person from India in prestigious ranking of global life sciences influencers
Kiran Mazumdar-Shaw, chairperson of Asia's…
Kiran Mazumdar Shaw ranked No. 2 in Global ‘Medicine Maker Power List’ 2015
She is the only India-based business leader featuring on the list
Kiran Mazumdar-Shaw ranked No. 2 in Global ‘Medicine Maker Power List’ 2015
She is the only India based business leader featuring on the list
Biocon top line grows 15 per cent in Q4 FY15
Research services subsidiary Syngene delivers 27 per cent growth
Syngene seeks approval for IPO, files DRHP
Offer allows Biocon to monetise its shareholding in Syngene
Biocon recognised for outstanding contribution to public health by WHO – India
Biocon's integrated healthcare initiatives is constantly engaged in improving the quality of life of several thousand communities…
Kiran Mazumdar-Shaw honoured by Federation University Australia
Appointed as an ambassador of the university for a three-year term
Biotech start ups get govt-backed equity fund
The BIRAC AcE Fund aims to accelerate growth of biotech startups